HeartBeam, Inc. (NASDAQ: BEATW) Stock Competitors & Peer Comparison
See BEATW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BEATW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BEATW | $0.01 | +0.00% | 6.3M | -0.02 | -$0.51 | N/A |
| ALC | $65.26 | +1.23% | 31.8B | 20.52 | $3.18 | +0.55% |
| STE | $211.00 | +0.99% | 20.6B | 20.25 | $10.42 | +1.23% |
| MLAB | $132.99 | -0.78% | 744.2M | 13.42 | $9.91 | +0.48% |
| QDEL | $10.83 | -1.01% | 738.5M | 8.08 | $1.34 | N/A |
| BWAY | $13.25 | -0.45% | 519.7M | 33.66 | $0.39 | N/A |
| MASS | $11.66 | +1.92% | 478.4M | -19.43 | -$0.60 | N/A |
| SI | $17.95 | +5.65% | 372M | -10.37 | -$1.73 | N/A |
| MOBI | $8.83 | -2.54% | 293.6M | -4.58 | -$1.93 | N/A |
| LAB | $0.73 | -1.70% | 284.7M | -10.39 | -$0.07 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
BEATW vs ALC Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, ALC has a market cap of 31.8B. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while ALC trades at $65.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas ALC's P/E ratio is 20.52. In terms of profitability, BEATW's ROE is -6.87%, compared to ALC's ROE of +0.03%. Regarding short-term risk, BEATW is less volatile compared to ALC. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check ALC's competition here
STERIS plc (NYSE: STE)
BEATW vs STE Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, STE has a market cap of 20.6B. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while STE trades at $211.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas STE's P/E ratio is 20.25. In terms of profitability, BEATW's ROE is -6.87%, compared to STE's ROE of +0.11%. Regarding short-term risk, BEATW is less volatile compared to STE. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check STE's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
BEATW vs MLAB Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, MLAB has a market cap of 744.2M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while MLAB trades at $132.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas MLAB's P/E ratio is 13.42. In terms of profitability, BEATW's ROE is -6.87%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, BEATW is less volatile compared to MLAB. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check MLAB's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
BEATW vs QDEL Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, QDEL has a market cap of 738.5M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while QDEL trades at $10.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas QDEL's P/E ratio is 8.08. In terms of profitability, BEATW's ROE is -6.87%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, BEATW is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check QDEL's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
BEATW vs BWAY Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, BWAY has a market cap of 519.7M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while BWAY trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas BWAY's P/E ratio is 33.66. In terms of profitability, BEATW's ROE is -6.87%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, BEATW is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
BEATW vs MASS Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, MASS has a market cap of 478.4M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while MASS trades at $11.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas MASS's P/E ratio is -19.43. In terms of profitability, BEATW's ROE is -6.87%, compared to MASS's ROE of -0.25%. Regarding short-term risk, BEATW is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
BEATW vs SI Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, SI has a market cap of 372M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while SI trades at $17.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas SI's P/E ratio is -10.37. In terms of profitability, BEATW's ROE is -6.87%, compared to SI's ROE of -0.26%. Regarding short-term risk, BEATW is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
BEATW vs MOBI Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, MOBI has a market cap of 293.6M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while MOBI trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas MOBI's P/E ratio is -4.58. In terms of profitability, BEATW's ROE is -6.87%, compared to MOBI's ROE of +0.80%. Regarding short-term risk, BEATW is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check MOBI's competition here
Standard BioTools Inc. (NASDAQ: LAB)
BEATW vs LAB Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, LAB has a market cap of 284.7M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while LAB trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas LAB's P/E ratio is -10.39. In terms of profitability, BEATW's ROE is -6.87%, compared to LAB's ROE of -0.18%. Regarding short-term risk, BEATW is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check LAB's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
BEATW vs ANIK Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, ANIK has a market cap of 276.8M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while ANIK trades at $20.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas ANIK's P/E ratio is 42.20. In terms of profitability, BEATW's ROE is -6.87%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, BEATW is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check ANIK's competition here
Edap Tms S.a. (NASDAQ: EDAP)
BEATW vs EDAP Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas EDAP's P/E ratio is -5.80. In terms of profitability, BEATW's ROE is -6.87%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, BEATW is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
BEATW vs NYXH Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, NYXH has a market cap of 162.1M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while NYXH trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas NYXH's P/E ratio is -0.64. In terms of profitability, BEATW's ROE is -6.87%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, BEATW is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check NYXH's competition here
Trinity Biotech plc (NASDAQ: TRIB)
BEATW vs TRIB Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, TRIB has a market cap of 142.8M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while TRIB trades at $6.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas TRIB's P/E ratio is -0.12. In terms of profitability, BEATW's ROE is -6.87%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, BEATW is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
BEATW vs APYX Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, APYX has a market cap of 105.3M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while APYX trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas APYX's P/E ratio is -12.50. In terms of profitability, BEATW's ROE is -6.87%, compared to APYX's ROE of -0.79%. Regarding short-term risk, BEATW is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
BEATW vs SKIN Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, SKIN has a market cap of 84.2M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while SKIN trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas SKIN's P/E ratio is -2.95. In terms of profitability, BEATW's ROE is -6.87%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, BEATW is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check SKIN's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
BEATW vs MDAI Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, MDAI has a market cap of 51.2M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while MDAI trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas MDAI's P/E ratio is -3.58. In terms of profitability, BEATW's ROE is -6.87%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, BEATW is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check MDAI's competition here
DarioHealth Corp. (NASDAQ: DRIO)
BEATW vs DRIO Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, DRIO has a market cap of 49.1M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while DRIO trades at $6.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas DRIO's P/E ratio is -1.15. In terms of profitability, BEATW's ROE is -6.87%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, BEATW is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
BEATW vs BEAT Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, BEAT has a market cap of 20.7M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while BEAT trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas BEAT's P/E ratio is -0.73. In terms of profitability, BEATW's ROE is -6.87%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, BEATW is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check BEAT's competition here
Spectral AI, Inc. (NASDAQ: MDAIW)
BEATW vs MDAIW Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, MDAIW has a market cap of 14.5M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while MDAIW trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas MDAIW's P/E ratio is -1.28. In terms of profitability, BEATW's ROE is -6.87%, compared to MDAIW's ROE of N/A. Regarding short-term risk, BEATW is less volatile compared to MDAIW. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check MDAIW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
BEATW vs WOK Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, WOK has a market cap of 4.5M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while WOK trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas WOK's P/E ratio is N/A. In terms of profitability, BEATW's ROE is -6.87%, compared to WOK's ROE of -0.19%. Regarding short-term risk, BEATW is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
BEATW vs QTEXW Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, BEATW's ROE is -6.87%, compared to QTEXW's ROE of N/A. Regarding short-term risk, BEATW is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
BEATW vs ITOC Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, ITOC has a market cap of 2.6M. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while ITOC trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas ITOC's P/E ratio is -0.89. In terms of profitability, BEATW's ROE is -6.87%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, BEATW is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
BEATW vs FEED Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, FEED has a market cap of 798K. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas FEED's P/E ratio is -0.15. In terms of profitability, BEATW's ROE is -6.87%, compared to FEED's ROE of -0.60%. Regarding short-term risk, BEATW is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
BEATW vs TIVC Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEATW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEATW stands at 6.3M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, BEATW is priced at $0.01 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEATW currently has a P/E ratio of -0.02, whereas TIVC's P/E ratio is -0.04. In terms of profitability, BEATW's ROE is -6.87%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, BEATW is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for BEATW.Check TIVC's competition here